U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3093130931Outcome of Rehabilitation Following Internally Fixed Ankle FracturesNot yet recruitingNo Results AvailableAnkle Fractures|FractureDevice: Aircast XP Walker boot|Device: Plaster Immobilisationhttps://ClinicalTrials.gov/show/NCT02160197
3093230932Nocturnal Insulin-Glucose in Hospital: Tight ControlNot yet recruitingNo Results AvailableType 1 DiabetesDevice: Artificial pancreas system consisting of a predictive rule-based algorithm integrated on the Medtronic Portable Glucose Control System (PGCS)https://ClinicalTrials.gov/show/NCT02160184
3093330933ANSeR- The Algorithm for Neonatal Seizure Recognition StudyCompletedNo Results AvailableNeonatal SeizuresDevice: Algorithm for Neonatal Seizure Recognitionhttps://ClinicalTrials.gov/show/NCT02160171
3093430934Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: Fesoterodine ER (fasted)|Drug: Fesoterodine SR3 (fasted)|Drug: Fesoterodine SR3 (fed)|Drug: Fesoterodine ER (fed)|Drug: Fesoterodine SR3 (sprinkle)|Drug: Fesoterodine ER (fasted)|Drug: Fesoterodine SR4 (fasted)|Drug: Fesoterodine SR4 (fed)|Drug: Fesoterodine ER (fed)|Drug: Fesoterodine SR4 (sprinkle)https://ClinicalTrials.gov/show/NCT02160158
3093530935Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney DiseaseRecruitingNo Results AvailableChronic Kidney Disease|Autosomal Dominant Polycystic Kidney DiseaseDrug: Tolvaptan (OPC-41061)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02160145
3093630936A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.RecruitingNo Results AvailableGlomerulonephritis, IGA|Peripapillary Crescent|Necrosis|Steroid NephropathyDrug: Methylprednisolone(intravenously in the 1st-2nd-3rd month )|Drug: Methylprednisolone(intravenously in the 1st-3rd-5th month)https://ClinicalTrials.gov/show/NCT02160132
3093730937Emotional and Change-related Attention in AutismRecruitingNo Results AvailableAutism Spectrum DisordersOther: MRI-based techniques|Other: EEGhttps://ClinicalTrials.gov/show/NCT02160119
3093830938First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid TumorsRecruitingNo Results AvailableAdvanced Stage Solid TumorsDrug: TEW-7197https://ClinicalTrials.gov/show/NCT02160106
3093930939Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric PatientsRecruitingNo Results AvailableAmbulatory Geriatric Outpatients at High Risk of Frailtyhttps://ClinicalTrials.gov/show/NCT02160093
3094030940Boceprevir Treatment in Liver Pre-transplant HCV PatientsRecruitingNo Results AvailableLate Complication From Liver TransplantDrug: Boceprevir 800mg/TID+Pegylated interferon alfa+Ribavirinhttps://ClinicalTrials.gov/show/NCT02160080
3094130941A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation PatchesCompletedNo Results AvailablePainDrug: Second generation BTDS patch|Drug: First generation BuTrans patchhttps://ClinicalTrials.gov/show/NCT02160067
3094230942Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)Active, not recruitingNo Results Availablethe Maintenance Phase After Kidney TransplantationDrug: Graceptor®https://ClinicalTrials.gov/show/NCT02160054
3094330943BGJ398 for Patients With Tumors With FGFR Genetic AlterationsRecruitingNo Results AvailableSolid Tumor|Hematologic MalignanciesDrug: BGJ398https://ClinicalTrials.gov/show/NCT02160041
3094430944Pain and Placebo Analgesia. Does Extended Information About Dental Procedures Reduce Pain Induced by Dental Treatment?CompletedNo Results AvailableAnxiety|OdontophobiaOther: anesthetics and extended information before dental treatment|Other: anesthetics and standard information before dental treatmenthttps://ClinicalTrials.gov/show/NCT02160028
3094530945Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruitingNo Results AvailableRecurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic LymphomaDrug: Ibrutinib|Other: Laboratory Biomarker Analysis|Drug: Lenalidomide|Biological: Rituximabhttps://ClinicalTrials.gov/show/NCT02160015
3094630946Incubator Weaning of Moderately Preterm InfantsRecruitingNo Results AvailableInfant, Newborn|Infant, Moderate PretermProcedure: Weaning from an incubator at a lower weight (1600 grams)|Procedure: Weaning from an incubator at a higher weight (1800 grams)https://ClinicalTrials.gov/show/NCT02160002
3094730947MLN0128 and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryRecruitingNo Results AvailableAdult Solid NeoplasmOther: Laboratory Biomarker Analysis|Drug: TORC1/2 Inhibitor INK128|Biological: Ziv-Aflibercepthttps://ClinicalTrials.gov/show/NCT02159989
3094830948Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in KoreaRecruitingNo Results AvailableHelicobacter Pylori InfectionDrug: Pantoprazole|Drug: Amoxicillin|Drug: Clarithromycin|Drug: Metronidazole|Drug: Tetracycline|Drug: Bismuthhttps://ClinicalTrials.gov/show/NCT02159976
3094930949High Intensity Training in Patients With Facioscapulohumeral Muscular DystrophyRecruitingNo Results AvailableFSHD - Facioscapulohumeral Muscular Dystrophy|Healthy SubjectsOther: Supervised training|Other: Unsupervised training|Other: Optional training|Other: Controlhttps://ClinicalTrials.gov/show/NCT02159963
3095030950Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerActive, not recruitingNo Results AvailableHormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate CancerOther: Laboratory Biomarker Analysis|Biological: Sipuleucel-T|Drug: Tasquinimodhttps://ClinicalTrials.gov/show/NCT02159950
3095130951In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by PeptidesCompletedNo Results AvailableMetastatic CancerOther: Blood sampling by vena punction.https://ClinicalTrials.gov/show/NCT02159937
3095230952Posture and Mobility Measurements of the Upper Quadrant in Asymptomatic Subjects by Means of a SmartphoneCompletedNo Results AvailablePosture and Mobility of the Upper Quadranthttps://ClinicalTrials.gov/show/NCT02159924
3095330953Oral Misoprostol for Cervical Priming Before HysteroscopyCompletedNo Results AvailableCervical Laceration|Adverse EffectsDrug: Misoprostol administered orally one hour before surgeryhttps://ClinicalTrials.gov/show/NCT02159911
3095430954EndoMAXX EVT Compared to EndoMAXXRecruitingNo Results AvailableMalignant Esophageal StricturesDevice: EndoMAXX EVT|Device: EndoMAXXhttps://ClinicalTrials.gov/show/NCT02159898
3095530955Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)RecruitingNo Results AvailableObstructive Sleep ApneaOther: Telemonitoringhttps://ClinicalTrials.gov/show/NCT02159885
3095630956Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) FailureRecruitingNo Results AvailableLeukemiaDrug: Omacetaxinehttps://ClinicalTrials.gov/show/NCT02159872
3095730957Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis PatientsNot yet recruitingNo Results AvailableEnd Stage Renal DiseaseDrug: Ertapenemhttps://ClinicalTrials.gov/show/NCT02159859
3095830958Effects of Mixed Herbs on Blood Glucose and Lipid Profile in T2DM PatientsCompletedNo Results AvailableType 2 Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT02159846
3095930959Intranasal Diagnostics in Food Allergy: a Feasibility StudyEnrolling by invitationNo Results AvailableFood AllergyOther: Intranasal challenge with active substance (food protein)|Other: Intranasal challenge with placebohttps://ClinicalTrials.gov/show/NCT02159833
3096030960Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerRecruitingNo Results AvailablePrimary Malignant Neoplasm of Ovary|FIGO Stages II to IVDrug: Decitabine (DTC Arm)|Drug: Paclitaxel and Carboplatin (TC Arm)https://ClinicalTrials.gov/show/NCT02159820

* Görseller ve İçerik tekif hakkına sahip olabilir